Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironment
Binita Chakraborty,Prabuddha Chakraborty,Michael C. Brown,Daniel Crowder,Aditi Goyal,Rachid Safi,Sandeep Artham,Megan Kirkland,Alessandro Racioppi,Patrick Juras,Debarati Mukherjee,Felicia Lim,Jovita Byemerwa,Kiana Gunn,Scott R. Floyd,Georgia Beasley,Suzanne Wardell,Ching-Yi Chang,Donald P. McDonnell
DOI: https://doi.org/10.1101/2024.12.26.630419
2024-12-26
Abstract:Phagocytic clearance of apoptotic cancer cell (efferocytosis) by tumor-associated macrophages (TAMs) contributes in a substantial manner to the establishment of an immunosuppressive tumor microenvironment. This puts in context our observation that the female steroid hormone 17β- estradiol (E2) facilitates tumor immune resistance through cancer cell extrinsic Estrogen Receptor (ERα) signaling in TAMs. Notable was the finding that E2 induces the expression of CX3CR1 in TAMs to enable efferocytosis of apoptotic cancer cells which results in the suppression of type I interferon (IFN) signaling. Mechanistically, E2 facilitates calcium-dependent activation of the transcription factor NFATC1, which in turn induces CX3CR1 expression. This drives macrophage polarization towards an immune-suppressive state, increasing the ability of TAMs to engulf pro- inflammatory apoptotic cancer cells. Genetic or pharmacological inhibition of the E2/ER/CX3CR1 axis reversed the efferocytic activity of TAMs, rescued E2-dependent suppression of type I IFN signaling, and potentiated intratumoral adaptive immune cell function. Efferocytosis following radiation-induced cancer cell apoptosis limits the efficacy of radiation therapy. Importantly, we determined that preconditioning with either ER-directed endocrine therapies or CX3CR1 inhibition enhanced the antitumor efficacy of radiation therapy by reversing macrophage suppression and reviving intratumoral T cell activation. Our work defines the mechanisms by which E2 increases the efferocytotic activity of TAMs to establish an immunosuppressive tumor microenvironment and demonstrates how this process can be reversed with endocrine therapies which target ERα.
Cancer Biology